[1]
Jennifer Sims-Mourtada et al. 2024. Dosimetric Evaluation of an Abscopal Response in an Oligometastatic Melanoma Patient Receiving Pembrolizumab and Stereotactic Body Radiation (SBRT) at the Same Time. Cancer Studies and Molecular Medicine . 9, 1 (Feb. 2024), 1–4.